Drugs Flashcards
D2 receptor antagonist antiemetics
I: 1 M A: 2 W: 2C/I, 1 caution I: 2 E: 2
Indication (1):
- N/V prophylaxis and tx (esp in reduced gut motility)
Mechanism:
- N/V triggered by gut irritation, drugs, motion and vestibular disorders and higher stimuli (sights/smells/emotions)
- D2 receptor is is main receptor in the chemoreceptor trigger zone (CTZ) - senses emotogenic substances in the blood
- Dopamine antagonists inhibits these receptors and promote gastric emptying
Adverse effects (2):
- Diarrhoea
- EPSEs via same mech as anti-psychotics (inc. oculogyric crisis)
- Domperidone doesn’t cause extrapyramidal syndromes as it doesn’t cross BBB
Warnings (2C/I, 1 caution):
- GI obstruction (C/I)
- Perforation (C/I)
- Avoid use in children/young adults increased risk of EPSEs
Interactions (2):
- Metoclopramide: don’t co-prescribe dopaminergic agents for Parkinson’s; also, risk of EPSEs increase when metoclopramide is prescribed with antipyschotics.
- Domperidone: these interactions don’t apply
Example drugs (2): Metoclopramide, domperidone
Quinolones
I: 4 M A: 6 W: 2 cautions I: 5 E: 3
Indications (4):
Only use second or third line (rapid resistance and C. diff association)
- UTIs
- Severe GI infections (e.g. Shigella, Campylobacter)
- LRTIs (only moxifloxacin and levofloxacin )
- Pseudomona aeruginosa (only ciprofloxacin)
Mechanism:
- Inhibit DNA synthesis to kill bacteria, especially aerobic gram -ve
- Moxifloxacin and levofloxacin are newer, they can work on gram +ve and gram -ve so can treat LRTIs
- Rapid resistance develops as bacteria either increase efflux of quinolones, reduce permeability to them or develop mutations against target enzymes of them
- Quinolone resistant genes are spread horizontally
Adverse effects (6):
- Mostly well tolerated
- GI upset
- Immediate and delayed hypersensitivity reactions
- Neuro effects
- Inflammation and rupture of muscle tendons
- Prolong QT interval
- Promote C. diff colitis
Warnings (2):
- People with risk of seizure
- QT prolongation
Interactions (5):
- Reduced absorption of quinolones if taken with drugs containing divalent cations e.g. calcium antacids
- Other drugs that prolong the QT interval or cause arrhythmias (amiodarone, antipsychotics, quinolones, macrolides, SSRIs)
- NSAIDs also increase risk of seizures
- Prednisolone also increases risk of tendon rupture.
- Ciprofloxacin inhibits some cytochrome P450 enzymes so risk of toxicity of drugs e.g. theophylline.
Example drugs (3): Ciprofloxacin, moxifloxacin, levofloxacin
Azathioprine
I: 3 M A: 12 W: 2C/I, 4 cautions I: 3
Indication (3):
- IBD remission maintainance (Crohn’s / UC)
- Rheumatoid Arthritis (DMARD)
- Organ transplant (reduces rejection risk)
Mechanism:
- Azathioprine is a pro-drug > metabolised to 6-Mercaptopurine
- Inhibits RNA replication (by inhibiting purine synthesis)
- Most cells can scavenge and recycle purines and continue functioning
- Lymphocytes cannot and are far more affected
- Metabolism of Azathioprine dependant on xanthine oxidase and thiopurine methyltransferase (TPMT)
- TPMT activity is reduced or absent in some people
Adverse effects (12):
- Bone marrow suppression > Leukopenia > risk of infection
- Nausea (divide daily dose > improves)
- Allergy
- D/V
- Rash
- Fever
- Myalgia
- Hypotension
- Pancreatitis
- Hepatotoxicity
- Veno-occlusive crisis
- Increased risk of Lymphomas (and some other tumors)
Warnings (6):
- Absent TPMT activity (C/I)
- Allergy - (C/I)
- Reduced TPMT activity (caution)
- Renal impairment (dose reduce)
- Hepatic Impairment (dose reduce)
- Pregnancy (do not start but might continue treatment if benefits outweigh risk)
Interactions (3):
- Allopurinol (+ other Xanthine oxidase inhibitors) > ++ toxicity
- Trimethoprim (+ other drugs that effect purine synthesis) > ++leukopenia
- Warfarin (increase warfarin dose as it reduces effect)
Methotrexate
I: 3 M A: 5 W: 2C/Is, 1 caution I: 3
Indication (3):
- RA DMARD
- Chemotherapy for many cancers including leukaemia, lymphoma and some solid tumours
- Treatment resistant psoriasis (including psoriatic arthritis)
Mechanism:
- Inhibits dihydrofolate reductase (converts dietary folic acid to FH4 - required for DNA / protein synthesis)
- This, therefore, prevents cellular replication
- Actively dividing cells are particularly sensitive to these effects, thus it works for cancers
- Also has anti-inflammatory and immunosuppressive effects (RA and psoriasis tx)
Adverse effects (5):
- Mucosal damage (sore mouth, GI upset)
- Bone marrow suppression (pancytopenia -> increased infection risk)
- Rare hypersensitivity reactions
- Long term use can cause hepatic cirrhosis or pulmonary fibrosis
- Risk of overdose with inappropriate regime
Warnings (3):
- Teratogenic, so avoid in pregnancy (and contraception during and for 3 months post tx)
- Severe renal impairment (C/I)
- Avoid in pts with abnormal liver function, as it can cause hepatotoxicity
Interactions (3):
- Drugs that ↓renal excretion > methotrexate toxicity (penicillins, ACE-I, ARB)
- Folate antagonists (increase risk of harm abs) - trimethoprim, phenytoin)
- Clozapine - increased neutropenia risk
Nicotine replacement
I: 1 M A: 2, V = 6, B = 5 W: 3 I: 2 E: 3
Indication:
- Smoking cessation, controls withdrawal symptoms
Mechanism
- Activates nicotinic acetylcholine receptors to prevent withdrawal symptoms
- Varenicline - partial agonist of nicotinic receptor, thus reducing withdrawal symptoms by agonising the receptor, and also the reward effects of smoking by only partially agonising the receptor.
- Bupropion - NA and dopamine reuptake inhibitor, so increased amounts in synaptic cleft
Adverse effects (4):
- Local irritation (patches, nasal spray).
- GI upset (oral nicotine) - nausea
- Headache
- Varenicline - insomnia, abnormal dreams, rarely suicidal ideation
- Bupropion - dry mouth, dizziness, psych (insomnia, depression, agitation), hypersensitivity reaction
Warnings (3):
- NRT - caution in haemodynamically unstable pts
- Bupropion & Varenicline - lowers seizure threshold, careful with psych conditions
- All of above - caution in hepatic/renal impairment
Interactions (2):
- Bupropion metabolised by CP450
- Bupropion + MAO-i or tricyclic antidepressants = increased risk of adverse effects
Example drugs (3): Nicotine, varenicline, bupropion
Alginates and antacids
I: 2 M A: 2 W: 3 I: 3 E: 2
Indication (2):
- GORD symptomatic relief
- Dyspepsia short-term relief
Mechanism:
- These drugs are most often taken as a combo: 1x alginates + 2 or more x antacids (i.e. Sodium bicarbonate, calcium carbonate, magnesium or aluminium salts)
- Antacids buffer stomach acids
- Alginates increase the viscosity of the stomach contents
- They may also inhibit pepsin production. Antacids alone can be used for short-term relief of dyspepsia.
Adverse effects (2):
- Magnesium salts can cause diarrhoea
- Aluminium salts can cause constipation.
Warnings (3):
- Caution paeds
- Na- and K- containing preps should be used with caution in patients w/ fluid overload or hyperkalaemia (i.e. renal failure)
- Some preps contain sucrose, which can worsen hyperglycaemia in DM
Interactions (3):
- Divalent cations in compound alginates can bind to other drugs»_space; decrease their absorption
- Antacids can reduce serum conc of many drugs»_space; effects dosage - applies to ACEI, some ABx (i.e. cephalosporins, ciprofloxacin, tetracyclines), bisphosphonates, digoxin, levothyroxine, and PPIs)
- By increasing alkalinity of urine, antacids can increase the excretions of aspirin and lithium
Example drugs (2): Gaviscon, peptac
Amiodarone
I: 1 M A: 1 ac, 5 chr W: 3 I: 3
Indication (1):
- Management of a wide range of tachycaridas, incl atrial Fib (AF), supraventricular tachycardia (SVT), ventricular tachycardia (VT) and refractory ventricular tachycardia (VF). It is generally used only when other therapeutic options (i.e. other drugs or electrical cardioconversion) are ineffective/inappropriate.
Mechanism:
- Amiodarone has many effects on myocardial cells, incl: blockade of Na, Ca and K channels; and antagonism of A- and B- adrenoceptors. These effects reduce spontaneous depolarisation (automaticity), slow conduction velocity and increase resistance to depolarisation (refractoriness), incl the AV node »_space; reduces ventricular rate in AF and atrial flutter
- Through other (unspecified) effects it may also increase chance of cardioversion to - and maintenance of - sinus rhythm. In SVT, Amiodarone may break re-entry circuit and restore sinus rhythm
- Amiodarone’s role in reducing automaticity makes it an option for prevention and treatment of VT and VF (although little clinical trials evidence for the latter)
Adverse effects (1 ac, 5 chr):
- In acute use, amiodarone causes relatively little myocardial depression though can cause hypotension if given via IV infusion
- In chronic use, it has many, often serious, side effects, inc: pneumonitis (lungs), bradycardia/AV block (heart), hepatitis (liver) and photosensitivity/grey discolouration (skin). Due to iodine content and structural similarities to thyroid hormone, it can cause thyroid abnormalities (hypo- and hyper-). Amiodarone has a v long half-life so takes months to be completely eliminated.
Warning (2):
- Severe hypotension (C/I)
- Heart block (C/I)
- Active thyroid disease (caution)
Interactions (3):
- Digoxin
- Diltiazem
- Verapamil
5 alpha reductase inhibitors
I: 1 M A: 3 W: 1 I: 0 E: 1
Indications (1):
- Second line for BPH, LUTs
Mechanism:
- 5α-reductase converts testosterone into the more active metabolite dihydrotesosterine, which stimulates prostatic growth
- Therefore the prostate gland is reduced by inhibiting intracellular 5α-reductase
- This can take several months so α-blockers are prefered initially
Adverse effects (3):
- Anti-androgen action: transient impotence and reduced libido, breast tenderness and gynaecomasia
- Reduced hair growth can help male pattern baldness
- Breast cancer has been reported
Warnings (1):
- Pregnant women should avoid as can lead to abnormal genitalia in male foetus (e.g. by exposure to semen in unprotected sex).
Interactions:
None
Example drugs (1): Finasteride
K sparing aldosterone antagonists
I: 3 M A: 4 W: 3C/I, 1 caution I: 2 E: 2
Indications (3):
- Ascites and oedema due to liver cirrhosis
- Chronic heart failure
- Primary hyperaldosteronism
Mechanism:
- Aldosterone acts on mineralocorticoid receptors in renal DCT to increase reabsorption of Na at expense of K. Aldosterone antagonists inhibit this by competitively bind to the receptors»_space; increased Na and water excretion; increase in K retention
- Effect greatest in primary hyperaldosteronism or when circulating aldosterone is increased (i.e. cirrhosis)
Adverse effects (4):
- Hyperkalaemia»_space; muscle weakness, arrhythmias and even cardiac arrest
- Can cause liver impairment and jaundice
- Stevens-Johnson syndrome
- Spironolactone causes gynaecomastia (?patient adherence)
Warnings (3C/I, 1 caution):
- Severe renal impairment (C/I)
- Hyperkalaemia (C/I)
- Addison’s disease (C/I)
- Aldosterone antagonists can X the placenta/appear in breast milk so should be avoided if pos in pregnant or lactating women
Interactions (2):
- Combo of aldosterone antagonist w/ other K-elevating drugs (i.e. ACEI and ARB) increases risk of hyperkalaemia - though can be effective v heart failure if monitored
- Aldosterone antagonists shouldn’t be combined w/ K supplements except in specialist practice
Example drugs (2): Spironolactone, epleronone
K sparing diuretics
I: 1 M A: 1 solo, 4 combined W: 3 C/I I: 3 E: 1, 2 combinations
Indication (1):
- Hypokalaemia - part of a combination therapy, for hypokalaemia due to loop or thiazide diuretics
Mechanism:
- Relatively weak diuretics alone, but in combination they can counteract potassium loss and enhance diuresis.
- Amilioride acts on the the DCT, inhibiting reabsorption of sodium by epithelial sodium channels (ENaC), leading to sodium and water excretion, and retention of potassium.
Adverse effects (1 solo, 4 combined): - GI upset When used with other diuretics - Dizziness - Hypotension - Urinary symptoms - Could still cause electrolyte abnormalities
Warnings (3):
- Severe renal impairment (C/I)
- Hyperkalaemia (C/I)
- Volume depletion (C/I)
Interactions (3):
- Don’t use with other potassium elevating drugs (Potassium supplements, aldosterone antagonists)
- Renal clearance of other drugs may be altered
- Digoxin and lithium should have doses adjusted
Example drugs (1, with 2 combinations): Amiloride is available individually, but often used as a combination tablet, with furosemide or hydrochlorothiazide. - Amiloride - Co- amilofruse - Co - amilozide
Triptans - 5-HT (serotonin) receptor agonists
I: 1 M A: 7 W: 4C/I I: 4 E: 1
Indication (1):
1) Acute migraine (+/- Aura), reduces duration and severity
Mechanism:
- Constrict cranial blood vessels (dilation believed to be important in migrane)
- Reduce neurotransmission along Trigeminal nerve / trigeminocervical complex
Adverse effects (7):
- Throat pain / discomfort
- Chest pain / discomfort
- Myocardial infarction (reported - rare)
- N/V
- Tiredness
- Dizziness
- Transient HTN
Warnings (4):
- Coronary Artery Disease (C/I)
- Cerebrovascular disease (C/I)
- Hemiplegic migraine (C/I)
- Basilar migraine (C/I)
Interactions (4): - MAOIs - Tramadol - SSRI - Tricyclics Note: Co-prescription increases risk of Serotonin toxicity / serotonin syndrome
Example drugs (1): Sumatriptan
Loop diuretics
I: 3 M A: 5 W: 2C/I, 4 cautions I: 3 E: 2
Indication (3):
- Acute pulmonary oedema - relief of breathlessness
- Chronic HF fluid overload
- Other Oedematous states - Symptomatic treatment of fluid overload, e.g. renal/liver failure
Mechanism:
- Act on the loop of Henle, where they inhibit the Na+/K+/2Cl- Co-transporter
- All three of these are being transported from lumen to epithelial cells - water follows, so inhibiting inhibits the water uptake
- Loop diuretics also have a direct effect on blood vessels, causing dilation of capacitance veins - reduces preload, and improves function of over-stretched heart muscles in heart failure
Adverse effects (5):
- Dehydration
- Hypotension
- Low almost any electrolyte (Hyponatremia, Hypokalemia, Hypochloraemia, Hypocalcemia, Hypomagnesaemia, metabolic alkalosis)
- They can act on a similar Na+/K+/2Cl- Co-transporter in the ear, so at high doses, loop diuretics can cause problems here, causing hearing loss and tinnitus
Warnings (2 C/I, 4 cautions):
- Hypovolemia (C/I)
- Dehydration (C/I)
- Hepatic encephalopathy (caution)
- Hypokalaemia (caution)
- Hyponatraemia (caution)
- Can worsen gout (caution)
Interactions (3):
- Renally excreted drugs (e.g. lithium)
- Digoxin toxicitiy may be increased, due to antidiurectic associated hypokalaemia
- It can also increase ototoxicity and nephrotoxicity of aminoglycosides
Example drugs (2): Furosemide, bumetanide
Dipeptidylpeptidase-4 (DPP4) Inhibitors
I: 2 M A: 2 W: 2 C/I, 6 cautions I: 4 E: 3
Indications (2):
- T2DM monotherapy (metformin contraindicated / not tolerated)
- T2DM as 2nd / 3rd agent where metformin +/- sulphonylurea are contraindicated, not tolerated or inadequate
Mechanism:
- Incretins (GLP-1 and GIP) are released in the gut
- Promote insulin release and supress glucagon release > lowering blood glucose
- Incretins are rapidly deactivated by Dipeptidylpeptidase-4 (DPP-4)
- Blood glucose is reduced by inhibiting DPP4
- Glucose dependant > doesn’t work at normal glucose levels
Adverse effects (2):
- Hypoglycaemia (but lower risk than SU or insulin)
- Pancreatitis (abdo pain > withdraw drug)
Warnings (2C/I, 6 cautions)
- Pregnancy (C/I)
- Breast Feeding (C/I)
- Elderly (>80)
- Pancreatitis
- Past Allergy
- Ketoacidosis
- Renal Impairment (mod-severe) > toxicity
Interactions (4) Risk of Hypoglycaemia increased by: - Alcohol - Beta Blockers Efficacy reduced by: - Thiazide Diuretics - Loop Diuretics
Example drugs (3) Sitagliptin, linagliptin, saxagliptin
SNRI antidepressants
I: 2 M A: 8 W: 3 I: 1 E: 2
Indication (2):
- Major depression where SSRIs aren’t tolerated
- Generalised anxiety disorder (venlafaxine)
Mechanism:
- Venlafaxine is a serotonin and NA reuptake inhibitors (SNRI) in the synaptic cleft
- Venlafaxine is a weaker antagonist of muscarinic and H1 receptors than tricyclic antidepressants
- Mirtazapine is an antagonist of the inhibitory pre-synaptic A2-adrenoceptor
- Mirtazapine is a potent antagonist of H1 but not muscarinic receptors
Adverse effects (8):
- GI upset (i.e. dry mouth, nausea, weight change, diarrhoea and constipation)
- CNS effects (i.e. headache, abnormal dreams, insomnia, confusion, convulsion and sedation (Mirtazapine))
- Hyponatraemia
- Serotonin syndrome
- Increase in suicidal thoughts/behaviours.
- Venlafaxine prolongs QT interval and can increase risk of ventricular arrhythmias
- Sudden withdrawal: GI upset, neurological, ‘flu-like symptoms and sleep disturbance
- Venlafaxine is associated w/ greater risk of withdrawal effects versus other antidepressants
Warnings (3):
- Elderly at higher risk of adverse effects
- Consider dose reduction hepatic/renal impairment
- Venlafaxine - CVD (caution)
Interactions (1):
- Combo of these and other antidepressants can increase risk of adverse effects and should, generally, be avoided
Example drugs (2): Venlafaxine, mirtazapine
Tetracyclines
I: 4 M A: 5 W: 3 I: 2 E: 2
Indications (4):
- Acne vulgaris (esp. if there are inflamed papules, pustules and/or cysts)
- Lower resp tract infections including infective exacerbations of COPD, pneumonia and atypical pneumonia
- Chlamydial infections including PID
- Typhoid, anthrax, malaria and Lyme disease
Mechanism:
- Inhibit bacterial protein synthesis
- Bind to ribosomal 30s subunit
- Prevents binding of transfer RNA to messenger RNA - prevents amino acids being made
- Therefore they are bacteriostatic, which enables the immune system to kill and remove
- Broad spectrum, resistance often due to an efflux pump preventing accumulation in bacteria
Adverse effects (5):
- GI upset
- Hypersensitivity reaction
- Oesophageal irritation, ulceration and dysphagia
- Exaggerated sunburn, discolouration and/or hypoplasia of tooth enamel in children
- Intracranial hypertension.
Warnings (3):
- Pregnant, breastfeeding
- Under age 12
- Avoid if renal impairment as anti-anabolic effects can raise plasma urea
Interactions (2):
- Tetracyclines bind to divalent cations. They should therefore not be given within 2 hours of calcium, antacids or iron, which will prevent antibiotic absorption
- Tetracyclines can enhance the anticoagulant effect of warfarin by killing normal gut flora that synthesise vitamin K
Example drugs (2): Doxycycline, lymecycline
Adrenaline
I: 2 M A: 3 W: 2 I: 1
Indications (2):
- Cardiac arrest
- Anaphylaxis immediate management
Mechanism:
- Adrenaline is a potent agonist of A1, A2, B1 and B2 adrenoreceptors»_space; multitude of sympathetic/parasympathetic effects
- A1: vasoconstriction of vessels supplying skin, mucosa and abdo viscera
- B1: Increases HR, force of contraction and myocardial excitability
- B2: Vasodilation of vessels supplying heart (use in cardiac arrest) and skeletal muscles; bronchodilatation and suppression of inflammatory mediator release from mast cells
Adverse effects (3):
- After use in cardiac arrest, often followed by adrenaline-induced hypotension
- After use in anaphylaxis, often causes anxiety, tremor, headache and palpitations
- Also, angina, MI and arrhythmias (particularly in patients w/ existing heart disease)
Warnings (2)
- Local vasoconstriction in HD (caution)
- Combo adrenaline-anaesthetic preps C/I in areas supplied by an end-artery (i.e. fingers/toes).
Interactions (1):
- In patients receiving B-blockers, adrenaline may cause widespread vasoconstriction (as A1 vasoconstriction not opposed by B2 vasodilation)
Example drugs (1) Adrenaline/Epinephrine
Beta 2 agonists
I: 3 M A: 7 W: 2 I: 1 E: 4
Indications (3):
- Asthma - short acting β2 agonists used to relieve breathlessness, Long acting β2 used as ‘step 3’ treatment (alwas given with corticosteroids)
- COPD - short-acting β2 agonists are used to relieve breathlessness, Long acting β2 used for second line therapy of COPD
- Hyperkalaemia - nebulised salbutamol used as an additional treatment
Mechanisms:
- β2 - receptors found in smooth muscle of the bronchi, GI, uterus, blood vessels
- Stimulation –> smooth muscle relaxation –> improves air flow
- Stimulate Na+/K+ -ATPase pumps on cell surface membranes, causing K+ from extracellular to intracellular compartment - makes it useful adjunct in hyperkalemia (especially if IV access difficult)
Adverse effects (7):
- Activation of β2 receptors in other tissues causes tachycardia, palpitations, anxiety, and tremor
- Promote glycogenolysis that can increase serum glucose concentration
- At high doses serum lactate levels may rise
- Long acting β2 - agonists can cause muscle cramps
Warnings:
- LABA should only be used in asthma when inhaled corticosterioids is also part of therapy - without a steroid LABAs associated with increased asthma deaths
- Be careful when prescribe for patients with CVD, especially in hyperkalaemia where high doses may be needed
Interactions (1)
- Beta blockers decrease effect
Examples (4)
Short acting: Salbutamol, terbutaline
Long acting: Salmeterol, formoterol
Phosphodiesterase (type 5 inhibitors)
I: 2 M A: 9 W: 5 I: 5 E: 2
Indication (2):
- Erectile dysfunction
- Primary Pulmonary hypertension
Mechanism:
- Selective inhibition of PDE5
- It is found primarily in the corpus cavernosum of penis and arteries of the lung
- For erection to occur, sexual stimulation is required.
- Releases NO which causes cGMP production, causing smooth muscle relaxation
- PDE5 causes breakdown of cGMP and this increases blood flow
- A simular mechanism is found in the pulmonary vasculature
Adverse effects (9): Resulting from vasodilation: - Flushing - Headache - Dizziness - Nasal congestion Progressing to: - Hypotension - Tachycardia - Palpitations - Priapism - Visual disorders (e.g. colour distortion) = prompt medical review
Warnings (5):
- Stroke
- Acute coronary syndrome
- Significant cardiovascular disease
- Severe Renal Impairment (lower dose)
- Severe hepatic impairment (lower dose)
Interactions (5): Drugs that increase NO: - Nitrates - Nicorandil Caution with other vasodilatiors - a-blockers - Calcium channel blockers. - Cytochrome p450 inhibitors
Example drugs (2) Slidenafil aka Viagra® (erectile disfunction) Revatio® (Pulmonary hypertension)
Trimethoprim
I: 2 M A: 6 W: 1 C/I, 3 cautions I: 3
Indications (2):
- Uncomplicated UTIs
- Co-trimoxazole (trimethoprim combined with sulfamethoxazole) to treat and prevent pneumocystis pneumonia in people with immunosuppression
Mechanism:
- Trimethoprim inhibits bacterial folate synthesis, slowing growth (bactiriostatic)
- Broad spectrum, Gram +ve and -ve, especially enterobacteria such as E, coli
- Widespread resistance (reduced intracellular accumulation and reduced sensitivity of target enzymes)
- When used with sulfonamides they work in synergy so there is complete inhibition of folate synthesis so bactericidal
Adverse effects (6):
- GI
- Skin rash (3-7%)
- Severe hypersensitivity reactions (more common with sulfonamides)
- Haemotological disorders
- Hyperkalamia
- High creatinine
Warnings (1 C/I, 3 cautions):
- First trimester (C/I)
- Folate def (caution)
- Renal impairment (caution)
- Dose reduction in neonates, elderly, HIV
Interactions (3):
- Potassium-elevating drugs (e.g. aldosterone antagonists, ACE inhibitors, angiotensin receptor blockers) predisposes to hyperkalaemia
- Use with other folate antagonists (e.g. methotrexate)
and drugs that increase folate metabolism (e.g. phenytoin) increases risk of adverse haematological effects
- Can enhance the anticoagulant effect of warfarin by killing normal gut flora that synthesise vitamin K
Adenosine
I: 1 M A: 2 W: (4 C/I, 2 caution) I: 4
Indication (1):
- 1st line diagnostic and therapeutic agent in supraventricular tachycardia (SVT)
Mechanism:
- Binds to heart adenosine receptors (G protein coupled)
- Decreased frequency of spontaneous depolarisations (automaticity) and increasing resistance to depolarisation (refractoriness)
- This slows sinus rate, conduction velocity and increases AV node refractoriness
- Many forms of SVT arise from re-entry circuits w/in the AV node. Increasing the AV node refractoriness breaks the re-entry circuit allowing normal SA node depolarisations to re-assert control (“cardioversion”)
- If the re-entry circuit does not involve the AV node, admin of adenosine at least blocks conduction to ventricles (i.e. in Atrial flutter), allowing closer inspection of atrial rhythm on ECG - may reveal true diagnosis
- Adenosine half-line in blood <10sec
Adverse effects (2):
- Bradycardia and even asystole (by interfering w/ SA and AV node conduction)
- Induces ‘impending doom’/sinking feeling/breathlessness sensation
Warnings (4 C/I, 2 caution):
- Hypotension (C/I)
- Coronary ischaemia (C/I)
- Decompensated HF (C/I)
- Bronchospasm (C/I)
- COPD (caution)
- Heart transplant (caution)
Interactions (4):
- Dipyridamole blocks cellular uptake of adenosine > prolongs + potentiates its effect»_space; dose should be halved
- Theophylline, aminophylline and caffeine are competitive antagonists of adenosine receptors»_space; reduce its effect»_space; patients may need higher doses
Thyroid hormones
I: 2 M A: 1 W: 2 I: 3 E: 2
Indications (2):
- Primary hypothyroidism
- Hypothyroidism secondary to hypopituitarism
Mechanism:
- Thyroid gland produces T4 which is converted into more active T3 in target tissues
- Levothyroxine is synthetic T4, it is usually given as a long term replacement of thyroid hormones
- Liothyronine is synthetic T3, it is usually reserved for emergences as it has a shorter half life and quicker onset and offset
Adverse effects (1): - Excessive doses lead to hyperthyroid symptoms (GI, cardiac and neuro)
Warnings (2):
- Cardiac ischaemia on those with coronary artery disease
- Addisonian crisis can occur in those with hypopituitarism if thyroid hormones are not preceded by corticosteroid therapy
Interactions (3):
- Antacids, calcium and iron salts reduce absorption so must not be given within same 4 hour window
- Higher dose may be needed if taking cytochrome P450 inducers, e.g. phenytoin, carbamazepine.
- Levothyroxine-induced changes in metabolism can
increase insulin or oral hypoglycaemic requirements in diabetes mellitus and enhance the effects of warfarin
Example drugs (2): Levothyroxine, liothyronine
Phenothiazine antiemetics
I: 2 M A: 4 W: 3 I: 7 E: 2
Indications (2):
- Prophylaxis and treatment of N/V, inc vertigo
- Schizophrenia, used as first generation (typical) antipsychotics
Mechanism:
- Antiemetic properties come from blocking D2 receptors in CTZ, and gut
- To a lesser extent histamine A1 and Ach (Mus) receptors in the vomiting centre and vestibular system
Adverse effects (4):
- Drowsiness and postural hypotension
- EPSEs (oculogyric crisis)
- In long term: (more likely in antipsychotic use) other extrapyramidal syndromes such as tardive dyskinesia may occur
- Like all antipsychotics, phenothiazines can cause QT- interval
Warnings (3):
- Hepatotoxic (avoid in liver disease)
- Should be avoided in patients susceptible to ACh side effects such as those in prostatic hypertrophy
- Reduce dose in elderly
Interactions (7):
- QT prolonging drugs
- Antipsychotics
- Amiodarone
- Ciprofloxacin
- Macrolides
- Quinine
- SSRIs
Example drugs (2): Prochlorperazine, chlorpromazine
Calcium channel blockers
I: 3 M A: A/N: 3, V: 4, D: mix W: V/D: 2, A/N: 1, 1 I: 1 E: 2, 2
Indications (3):
- Amlodipine used as second line treatment of HTN
- All Ca channel blockers can be used to control symptoms in stable angina
- Diltiazem and verapamil used to control cardiac rate in people with supraventricualr arrhythmias (inc. supraventricular tachycardia, atrial flutter, and a. fib)
Mechanism:
- Decrease Ca2+ entry into vascular and cardia cells, decreasing intracellular Ca –> relaxation and vasodilaiton in arterial smooth muscle –> lower arterial pressure
- Supress cardiac conduction across AV node, slowing ventricular rate
- Reduced cardiac rate, and contractility and afterload decrease myocardial oxygen demand, preventing angina
Two types:
- Dihydropyridines - amlodipine and nifedipine are relatively selective for vasculature
- Non-dihydropyridines - more selective of heart - verapamil (most selective), and diltiazem
Adverse effects (many):
- Amlodipine/Nifedipine - ankle swelling, flushing, palpitations
- Verapamil - constipation, rarely bradycardia, heart block, and heart failure
- Diltiazem - mixed vascular and cardiac actions so can cause all the above
Warnings (4):
- Verapamil/diltiazem - caution if poor left ventricular function, or AV nodal delay
- Amlodipine/nifedine - avoid in unstable angina as vasodilation causes reflex increase in contractility and tachycardia which increases myocardial oxygen demand.
- Avoid in aortic stenosis –> collapse
Interactions (1):
- Beta blockers - can cause heart failure, bradycardia, andasystole
Examples (2,2):
- Dihydropyridines - amlodipine and nifedipine
- Non-dihydropyridines - verapamil and diltiazem
Digoxin
I: 2 M A: 7 W: I: 3 C/I, 3 caution
Indication (2):
- In atrial fibrillation and atrial flutter, it’s used to reduce the ventricular rate
- In severe heart failure, it’s used as a third line treatment in those already taking an ACE inhibitor, Beta blocker, and either an aldosterone antagonist or ARB
Mechanism:
- It’s negatively chronotropic (reduces heart rate)
- It’s positively inotropic (Increases force of contraction)
- In atrial fibrillation and flutter it increases parasympathetic tone, which reduces conduction at the AV node, which reduces the ventricular rate
- In heart failure, it acts on the myocytes via inhibition of of the NaK ATPase pumps, causing Na+ to acculmulate in the cells. Removal of Ca2+ requires low intracellular Na+ so elevation of Na+ causes Ca2+, which increase contractile force
Adverse effects (7):
- Bradycardia
- GI disturbance
- Rash
- Dizziness
- Visual disturbance (blurry or yellow vision)
- Can cause digoxin toxicity which will cause arrhythmias
- Theraputic index is low, meaning a slightly incorrect dose is bad
Warnings (3 C/I, 3 caution):
- Second degree heart block (C/I)
- Intermittent complete heart block (C/I)
- Patients at risk or with ventricular arrhymias (C/I)
- Dose should be reduced in renal failure as eliminated by the kidneys.
- Electrolyte abnormalities increase risk of digoxin toxicity, including hypokalemia, hypomagnesaemia, hypercalcaemia
Hypokalemia is the most important of these, as digoxin competes with potassium for the NaK ATPase pump. If potassum is low, competition is reduced, and digoxin’s effects are enhanced.
Interactions:
Loop and thiazide diuretics can increase risk of digoxin toxicity by causing hypokalemia.
Amiodorone, calcium channel blockers, spironolactone, and quinine can all increase the plasma concentration of digoxin.